What the pelvic floor can tell health care providers about how to treat chronic pelvic pain

Patients with less tender pelvic floor muscles might benefit more from physical therapy while those with widespread pelvic floor pain may need systemic treatments as well to address their pain.

5:00 AM

Author | Mary Clare Fischer

Jacob Dwyer, Justine Ross, Michigan Medicine

Among patients with chronic pelvic pain and urinary issues, those with intense soreness throughout their pelvic floors are more likely to experience pain that is driven by the central nervous system. As a result, they might benefit from systemic treatments that address their overall pain, according to a recent multi-site study.

Patients with urologic chronic pelvic pain syndrome who have a lesser degree of pelvic floor tenderness might be better candidates for treatments that target their pelvic floor tenderness specifically, such as physical therapy, the researchers found.

"One of the challenges of treating pelvic pain is that patients often have more than one problem going on," said Priyanka Gupta, M.D., a urologic surgeon at University of Michigan Health, a clinical associate professor of urology at the University of Michigan Medical School and the first author of the paper. "As clinicians, we're trying to figure out what therapies are better for patients and for pain conditions it can be trial and error to find a therapy that is helpful. One aim of this study was to determine if we can better categorize patients at the beginning of their care so we can target our treatments better."

This paper is one of several analyzing the results from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network, an NIH-backed initiative that has spanned almost 15 years and included researchers in a range of disciplines from six institutions. (J. Quentin Clemens, M.D., the associate chair for research in urology at Michigan Medicine, is the chair of the MAPP network.)

Gupta notes that the MAPP network plans to publish a clinical summary of their various studies' findings in the near future.

Paper cited: "Is Pelvic Floor Muscle Tenderness a Distinct Urologic Chronic Pelvic Pain Syndrome Phenotype? Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Symptom Pattern Study," The Journal of Urology. DOI: 10.1097/JU.0000000000002679

More Articles About: Lab Notes Pelvic Problems Urology Physical Therapy Gynecology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories pink blue orange coloring woman looking at toilet, a calendar, a woman drinking purple drink, pink pills
Health Lab
Do your UTIs keep returning?
A Michigan Medicine urogynecologist discusses what urinary tract infections are, how they are treated and what new research is on the horizon.
Pink head brain maze
Health Lab
The malfunction of an undamaged brain
People with these two functional neurologic disorders often go misdiagnosed
Person tying shoes on floor
Health Lab
Different pain types in multiple sclerosis can cause difficulty staying active
Chronic pain can present in multiple forms for multiple sclerosis patients. Some forms make it harder to stay active than others.
gynecology hand with swab
Health Lab
7 things you need to know about Pap smears
Learn more about Pap smears and HPV testing, thanks to doctors at Michigan Medicine.
woman holding back in pain sitting on couch
Health Lab
What to do when pain lingers
Experts at Michigan Medicine are focusing on helping people with chronic pain, which is defined as pain that lasts more than three months.
woman sitting and using cell pill crib teddy bear blue pink
Health Lab
A pill to treat postpartum depression? It’s here
The fast-acting postpartum pill offers more convenience than the postpartum depression infusion treatment, brexanolone (branded Zulresso), which has been available since 2019, but cost concerns remain. As with all mental health medications, zuranolone should be paired with psychosocial treatment to treat all factors contributing to the disease.